IL141325A0 - Tan-1057 derivatives - Google Patents
Tan-1057 derivativesInfo
- Publication number
- IL141325A0 IL141325A0 IL14132599A IL14132599A IL141325A0 IL 141325 A0 IL141325 A0 IL 141325A0 IL 14132599 A IL14132599 A IL 14132599A IL 14132599 A IL14132599 A IL 14132599A IL 141325 A0 IL141325 A0 IL 141325A0
- Authority
- IL
- Israel
- Prior art keywords
- derivatives
- tan
- disorders
- humans
- animals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19838998A DE19838998A1 (de) | 1998-08-27 | 1998-08-27 | Neue Naturstoffderivate |
| PCT/EP1999/006124 WO2000012484A1 (de) | 1998-08-27 | 1999-08-20 | Tan-1057 derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL141325A0 true IL141325A0 (en) | 2002-03-10 |
Family
ID=7878913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14132599A IL141325A0 (en) | 1998-08-27 | 1999-08-20 | Tan-1057 derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6617332B1 (xx) |
| EP (1) | EP1117652B1 (xx) |
| JP (1) | JP4533535B2 (xx) |
| KR (1) | KR20010099629A (xx) |
| CN (1) | CN1324348A (xx) |
| AT (1) | ATE267816T1 (xx) |
| AU (1) | AU759618B2 (xx) |
| BG (1) | BG105275A (xx) |
| BR (1) | BR9913337A (xx) |
| CA (1) | CA2342102C (xx) |
| DE (2) | DE19838998A1 (xx) |
| EE (1) | EE200100125A (xx) |
| ES (1) | ES2219105T3 (xx) |
| HK (1) | HK1041884A1 (xx) |
| HR (1) | HRP20010135A2 (xx) |
| HU (1) | HUP0103316A3 (xx) |
| ID (1) | ID28365A (xx) |
| IL (1) | IL141325A0 (xx) |
| NO (1) | NO20010940L (xx) |
| NZ (1) | NZ510153A (xx) |
| PL (1) | PL346143A1 (xx) |
| SK (1) | SK2622001A3 (xx) |
| TR (1) | TR200100637T2 (xx) |
| WO (1) | WO2000012484A1 (xx) |
| ZA (1) | ZA200101038B (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1113008A1 (en) * | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents |
| US20040204404A1 (en) * | 2002-09-30 | 2004-10-14 | Robert Zelle | Human N-type calcium channel blockers |
| EP2220093A4 (en) * | 2007-12-20 | 2011-06-22 | Reddys Lab Ltd Dr | METHOD FOR THE PRODUCTION OF SITAGLIPTIN AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF |
| WO2011046007A1 (ja) | 2009-10-15 | 2011-04-21 | 国立大学法人徳島大学 | ジエチレントリアミン五酢酸誘導体の製造方法およびジエチレントリアミン五酢酸誘導体 |
| MX2012004341A (es) | 2009-10-16 | 2012-10-05 | Rib X Pharmaceuticals Inc | Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos. |
| CN102725274A (zh) | 2009-10-16 | 2012-10-10 | Rib-X制药公司 | 抗微生物化合物和其制备和使用方法 |
| EA201270566A1 (ru) | 2009-10-16 | 2012-11-30 | Риб-Экс Фармасьютикалз, Инк. | Противомикробные соединения и способы их получения и применения |
| TWI629277B (zh) * | 2009-10-16 | 2018-07-11 | 梅林塔療法公司 | 抗微生物性化合物，及製法及其用途 |
| CA2833169A1 (en) | 2011-04-15 | 2012-12-20 | Rib-X Pharmaceuticals, Inc. | Antimicrobial compounds and methods of making and using the same |
| RU2475479C1 (ru) * | 2011-12-23 | 2013-02-20 | Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) | Вазоконстрикторное средство |
| MX2016003046A (es) | 2013-09-09 | 2016-09-08 | Melinta Therapeutics Inc | Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos. |
| US10106543B2 (en) | 2013-09-09 | 2018-10-23 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| SG11201707346RA (en) | 2015-03-11 | 2017-10-30 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2873340B2 (ja) * | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質ｔａｎ―１０５７，その製造法および用途 |
| US6110925A (en) | 1997-08-07 | 2000-08-29 | Research Corporation Technologies, Inc. | Antibiotic for methicillin resistant bacteria |
-
1998
- 1998-08-27 DE DE19838998A patent/DE19838998A1/de not_active Ceased
-
1999
- 1999-08-20 HU HU0103316A patent/HUP0103316A3/hu unknown
- 1999-08-20 EP EP99968234A patent/EP1117652B1/de not_active Expired - Lifetime
- 1999-08-20 DE DE59909607T patent/DE59909607D1/de not_active Expired - Lifetime
- 1999-08-20 JP JP2000567514A patent/JP4533535B2/ja not_active Expired - Fee Related
- 1999-08-20 CA CA002342102A patent/CA2342102C/en not_active Expired - Fee Related
- 1999-08-20 ID IDW20010483A patent/ID28365A/id unknown
- 1999-08-20 SK SK262-2001A patent/SK2622001A3/sk unknown
- 1999-08-20 ES ES99968234T patent/ES2219105T3/es not_active Expired - Lifetime
- 1999-08-20 TR TR2001/00637T patent/TR200100637T2/xx unknown
- 1999-08-20 KR KR1020017002417A patent/KR20010099629A/ko not_active Application Discontinuation
- 1999-08-20 CN CN99812643A patent/CN1324348A/zh active Pending
- 1999-08-20 WO PCT/EP1999/006124 patent/WO2000012484A1/de not_active Application Discontinuation
- 1999-08-20 BR BR9913337-7A patent/BR9913337A/pt not_active IP Right Cessation
- 1999-08-20 EE EEP200100125A patent/EE200100125A/xx unknown
- 1999-08-20 PL PL99346143A patent/PL346143A1/xx not_active Application Discontinuation
- 1999-08-20 IL IL14132599A patent/IL141325A0/xx unknown
- 1999-08-20 AU AU10099/00A patent/AU759618B2/en not_active Ceased
- 1999-08-20 US US09/763,711 patent/US6617332B1/en not_active Expired - Fee Related
- 1999-08-20 NZ NZ510153A patent/NZ510153A/xx unknown
- 1999-08-20 AT AT99968234T patent/ATE267816T1/de not_active IP Right Cessation
-
2001
- 2001-02-07 ZA ZA200101038A patent/ZA200101038B/en unknown
- 2001-02-20 BG BG105275A patent/BG105275A/xx unknown
- 2001-02-23 NO NO20010940A patent/NO20010940L/no unknown
- 2001-02-26 HR HR20010135A patent/HRP20010135A2/hr not_active Application Discontinuation
-
2002
- 2002-05-17 HK HK02103758.4A patent/HK1041884A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2342102A1 (en) | 2000-03-09 |
| BG105275A (en) | 2001-11-30 |
| JP4533535B2 (ja) | 2010-09-01 |
| HUP0103316A2 (hu) | 2002-04-29 |
| EE200100125A (et) | 2002-06-17 |
| CN1324348A (zh) | 2001-11-28 |
| BR9913337A (pt) | 2001-05-15 |
| TR200100637T2 (tr) | 2001-10-22 |
| PL346143A1 (en) | 2002-01-28 |
| ES2219105T3 (es) | 2004-11-16 |
| NZ510153A (en) | 2002-12-20 |
| ZA200101038B (en) | 2002-02-07 |
| JP2002523496A (ja) | 2002-07-30 |
| DE59909607D1 (de) | 2004-07-01 |
| EP1117652B1 (de) | 2004-05-26 |
| HUP0103316A3 (en) | 2002-06-28 |
| ID28365A (id) | 2001-05-17 |
| KR20010099629A (ko) | 2001-11-09 |
| SK2622001A3 (en) | 2001-11-06 |
| WO2000012484A1 (de) | 2000-03-09 |
| AU759618B2 (en) | 2003-04-17 |
| HRP20010135A2 (en) | 2002-02-28 |
| AU1009900A (en) | 2000-03-21 |
| EP1117652A1 (de) | 2001-07-25 |
| ATE267816T1 (de) | 2004-06-15 |
| HK1041884A1 (zh) | 2002-07-26 |
| DE19838998A1 (de) | 2000-03-09 |
| CA2342102C (en) | 2008-10-28 |
| NO20010940D0 (no) | 2001-02-23 |
| US6617332B1 (en) | 2003-09-09 |
| NO20010940L (no) | 2001-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY124122A (en) | Heterocyclic derivatives | |
| MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
| IL162214A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| NZ284846A (en) | 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof | |
| BG105588A (en) | Anthranilic acide amides and the use thereof as medicaments | |
| MY133392A (en) | Novel substituted pyrazole derivatives | |
| PL367682A1 (en) | Dolastatin 10 derivatives | |
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| GB9715894D0 (en) | Heterocyclic derivatives | |
| MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
| CA2415354A1 (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
| PL346143A1 (en) | Tan-1057 derivatives | |
| UA49884C2 (uk) | ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ | |
| BG105731A (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| GB9809349D0 (en) | Heterocyclic derivatives | |
| MY120683A (en) | New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals. | |
| MXPA04005552A (es) | Analogos de vitamina d. | |
| MXPA04001328A (es) | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. | |
| PT1427417E (pt) | Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos | |
| IL162314A (en) | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation, pharmaceutical compositions comprising them and uses thereof | |
| BG103260A (en) | The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis | |
| SI1196129T1 (sl) | Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante | |
| MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. |